Clinical Trials Browser

Phase NA × Carcinoma, Non-Small-Cell Lung × Fluorodeoxyglucose F18 × Clear all

NCT00732563 2017-10-18

Fludeoxyglucose F 18 in Detecting Lymph Node Metastasis in Patients With Stage I or Stage II Non-Small Cell Lung Cancer That Can Be Removed by Surgery

Phase NA Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02059889 2016-12-16

Diffusion-weighted MRI for Individualized Radiation Therapy Planning of Lung Cancer

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung

NCT00004138 2016-07-13

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

Phase NA Completed

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01254591 2013-08-26

Positron Emission Tomography/Computed Tomography Scanning Before Surgery in Patients With Non-Small Cell Lung Cancer, Colorectal Cancer, Breast Cancer, Esophageal Cancer, or Head and Neck Cancer

Phase NA Unknown

BreastGastrointestinalHead & NeckThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Lung Neoplasms, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Tongue Neoplasms, Colorectal Neoplasms

NCT01314677 2012-06-29

Fludeoxyglucose F 18 PET/CT Scans in Predicting Therapy Response in Patients With Stage IIIA Non-Small Cell Lung Cancer Undergoing Chemoradiation

Phase NA Withdrawn

Carcinoma, Non-Small-Cell Lung